Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Steroid Biochem Mol Biol. 2013 Oct 29;142:155–170. doi: 10.1016/j.jsbmb.2013.09.008

Figure 8.

Figure 8

Although it is FDA-approved for osteoporosis prevention, but not treatment, results from the Women's Health Initiative (WHI) HT trials provide randomized clinical trial evidence for the efficacy of estrogen used alone (E only) or with a progestin (E+P) in reducing the incidence of hip, vertebral, nonvertebral, and total fractures as shown in this slide.